CompletedNCT07550504
A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV
PHASE2 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- April 24, 2026
immortal.lifeTrial registrations containing the exact intervention label SB11 PFS.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 30 planned enrolment
PHASE2 · 34 planned enrolment